Tephrosia purpurea (T. purpurea), a plant belonging to Fabaceae (pea) family, is a well-known Ayurvedic herb and is commonly known as Sarapunkha in traditional Indian medicinal system. Described as "Sarwa wranvishapaka", i.e. having capability to heal all types of wounds, it is particularly recognized for its usage in splenomegaly. Towards exploring the comprehensive effects of T. purpurea against polycystic ovarian syndrome (PCOS), its phytochemicals were extensively reviewed and their network pharmacology evaluation is carried out in this study. The complex regulatory potential of its 76 phytochemicals (PCs) against PCOS are enquired by developing and analyzing high confidence tripartite networks of protein targets of each phytochemical at both pathway and disease association scales. We also developed a highconfidence human PPI sub-network specific to PCOS, explored its modular architecture and probed the drug-like phytochemicals (DPCs) having multi-module regulatory potential. The proteins belonging to endocrine system were identified as major targets of the PCs. The study reports 30 DPCs based on ADMET and drug-like properties. Multi-targeting and synergistic capacities of the 12 DPCs against 10 protein targets were identified and evaluated using molecular docking and interaction analyses. The study concludes by highlighting a couple of DPCs as potential sources of PCOS regulators.
putative drug-like candidates (i.e. DPCs). The drugability of the compounds were further assessed by performing their structural similarity with the existing drugs of DrugBank. The polypharmacological action of phytochemicals present in T. purpurea was inferred using the approach of network pharmacology where polypharmacological activity of a compound was estimated on the basis of number of their protein targets. The functional relevance of the protein targets have been identified using human pathway mapping, disease-association and module participation. High confidence DPC-protein target pairs associated with PCOS were predicted and subjected for the molecular docking and interaction analysis. The series of steps followed in this study are represented in Figure 1 . 
Materials and methods

Data information and collection
A list of phytochemicals reported in T. purpurea was compiled using database sources available in public domain and manually curating the PubMed articles. Four public databases, namely, (i) Dr. Duke's phytochemical database (Duke, 2017) , (ii) PCIDB (Phytochemical interaction database) (http://www.genome.jp/db/pcidb), (iii) TCMSP (Traditional Chinese Medicine Systems Pharmacology) (Ru et al., 2014) , and (iv) IMPPAT (Indian Medicinal Plants, And Therapeutics) (Mohanraj et al., 2018) were searched for retrieving the information of phytochemicals present in T. purpurea.
Also, articles in PubMed, an archive of biomedical and life science research manuscripts, were manually inspected to collect the relevant publications for enlisting the phytochemicals of T.
purpurea. The phytochemicals compiled from both, literature survey and database mining were examined to remove duplicate entries. Two chemical databases i.e. PubChem (Bolton, Wang, Thiessen, & Bryant, 2008) and ChEMBL (Bento et al., 2014) were used to obtain the chemical information of the phytochemicals reported in T. purpurea.
Clustering and chemical distribution of phytochemicals
A chemical class was assigned to each phytochemical using ClassyFire, an annotated and rapid chemical classification method which uses the information of chemical structure features for hierarchical classification. (Djoumbou Feunang et al., 2016) . Clustering of phytochemicals was performed using clustering toolbox of ChemMine tools. A hierarchical clustering algorithm was opted for searching compound similarities based on Tanimoto coefficient and atom-pair based descriptors.
Based on the Lipinski's rule of five, a chemical compound bearing molecular weight (MW) < 500 daltons; number of hydrogen bond acceptor (HA n ) < 10; number of hydrogen bond donor (HD n ) and logP value < 5 is likely to be a candidate drug molecule (Lipinski, Lombardo, Dominy, & Feeney, 1997) . For this, the calculation of the ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) properties were performed using pKCSM based on the graphbased signatures (Pires, Blundell, & Ascher, 2015) . Only phytochemicals following the Lipinski's rule were considered for the subsequent analysis and refereed as putative drug-like phytochemicals i.e. DPCs. The ADMET values of 30 DPCs are given in the Supplementary 
PCOS-gene library
The proteins associated with PCOS were collected from two databases, namely, 1) PCOSKB, a web-based online knowledgebase containing the manually curated information of 241 PCOSassociated genes, SNPs, associated diseases, pathway and GO association (Joseph, Barai, Bhujbalrao, & Idicula-Thomas, 2015) . 2) PCOSbase, having a collection of PCOS-related genes and providing information of 8,185 genes compiled from online sources (which includes OMIM, MalaCards, DisGeNET, DISEASES and DGA) and expression studies (Afiqah-Aleng, Harun, Muhammad, Azlan, & Mohamed-Hussein, 2017) . The gene-list obtained from both the sources was compiled and duplicate entries were removed to obtain a unique set of 8,199 genes. This dataset of 8,199 genes constitutes the PCOS-gene library ( Supplementary Table- 2). The collected genes were mapped to their respective Uniprot Ids, and 7,972 (list-1) Uniprot Ids were returned for these 8,199 genes.
Target identification
The potential protein targets of the phytochemicals of T. purpurea were obtained from three database sources, namely, (1) STITCH 5.0 (Search Tool for the interaction of chemicals and protein), that integrates the information about interactions from metabolic pathways, crystal structures, binding experiments and drug-target relationships (Szklarczyk et al., 2016) . The confidence score of ≥ 0.4 was used to screen high confidence protein targets of the query molecule.
(2) Binding DB, that is a database of experimentally known binding affinities of protein-ligand pairs (Liu, Lin, Wen, Jorissen, & Gilson, 2007) . The similarity score of ≥ 0.85 was used to retrieve binding data of the query molecule.
(3) SwissTargetPrediction, that returns top-15 protein targets based on the combined score of 2D and 3D similarity measures between the query molecule and its most similar ligands (Gfeller et al., 2014) .
Similarity index calculation
The chemical similarity between the phytochemicals of T. purpurea and the drugs present in DrugBank was assessed on the basis of Tanimoto coefficient ( ) calculated using OpenBabel v2.4.1 (O'Boyle et al., 2011) . The structural comparison between the two compounds was performed using FP2; a path based molecular fingerprints which index linear fragments of the molecule from 1-7 atoms where molecular fingerprints help to encode the chemical structure of the compounds in the form of binary digits.
between two chemical compounds X and Y is given by,
where, ( ) and ( ) are the number of molecular fingerprints in compounds X and Y, respectively and ( , ) is the number of molecular fingerprints present in both X and Y (Gohlke et al., 2015; Willett, Barnard, & Downs, 1998) . The value of ranges from 0 to 1, with 1 representing maximum and 0 representing no similarity.
For the comparison, PCs passing the drug-likeliness criterion (i.e. 30 DPCs) and approved drugs of DrugBank were considered for the analysis. Tanimoto score of DPC-Drug pairs between 30
DPCs and 2,384 approved drugs are given in Supplementary Table 3. 2.6 Network construction and analysis STRING v11.0, an integrated database of the protein-protein interaction data was used to identify interaction among PCOS proteins (Szklarczyk et al., 2015) . Only the interactions limited to Homo sapiens with the confidence interaction score ≥ 0.9 was used to construct the high confidence human PPI-subnetwork specific to PCOS. Molecular COmplex DEtection algorithm;
MCODE was used to organize the obtained PPI into functional modules (Bader & Hogue, 2003) .
Module represents a set of proteins which tend to cluster together and work in a coordinative manner to perform a particular function (Barabási, Gulbahce, & Loscalzo, 2011) . The biological relevance of proteins constituting a module was detected using the functional annotation tool provided by DAVID Bioinformatics Resources 6.8 (Dennis et al., 2003) .
To examine the poly-pharmacological actions of various phytochemicals, networks involving associations among the phytochemicals (PCs), protein-targets (PTs) of PCs, biochemical-pathways (BPs) and disease-association (DAs) of PTs were constructed and studied using Cytoscape v3.2.1 (Shannon et al., 2003) . The knowledge of biological pathways with which the identified protein targets are associated was obtained from KEGG database (Kyoto encyclopedia of genes and genome) (Ogata et al., 1999) . A database having comprehensive gene-disease associations called DisGeNET (Piñero et al., 2017) was used to investigate the role of PCs against various disease classes.
2.7
In-silico molecular docking and interaction studies
AutoDock was used to predict all the favorable conformations of ligand at the active sites of protein targets. This technique combines simulated annealing and a grid-based method for conformation searching (Goodsell, Morris, & Olson, 1996) . Docking studies were performed using Lamarckian genetic algorithm. Ligplot+ was used for obtaining the 2D representations of molecular interaction in protein-ligand complexes (Wallace et al., 1995) .
Results and discussion
Phytochemical dataset preparation
A comprehensive list of phytochemicals present in T. purpurea was prepared using extensive literature review and mining of public-domain databases having information about natural products. A total of 76 phytochemicals could be found and each of them was allotted with a unique identifier. Detailed information of all the phytochemicals is presented in Table 1 . (Duke, 2017) 2. TPU_02 BETULINIC-ACID 64971 (Duke, 2017) 3. TPU_03 LUPEOL 259846 (Duke, 2017) 4. TPU_04 ROTENONE 6758 (Duke, 2017) 5. TPU_05 RUTIN 5280805 (Duke, 2017) 6. TPU_06 TEPHROSIN 114909 (Duke, 2017) 7. (Palbag, Dey, & Singh, 2014) 53. TPU_53 TEPIRINDOLE 68915 (Palbag et al., 2014) 54. TPU_54 OVALITENONE 627910 (Rao & Raju, 1984) 55. TPU_55 PRAECANSONE A 9999819 (Rao & Raju, 1984) 56. TPU_56 PRAECANSONE B 10090306 (Rao & Raju, 1984) 57. TPU_57 3'-METHOXYDAIDZEIN 5319422 (Chang et al., 1997) 58. TPU_58 TERPURINFLAVONE N/A (Juma et al., 2011) 59. TPU_59 4-METHOXYBENZOFURAN-5-CARBOXAMIDE 122195902 (Shill et al., 2015) 60. TPU_60 TACHROSIN 1023499 (Pelter, Ward, Rao, & Raju, 1981) 61. TPU_61 TEPHROGLABRIN N/A (Pelter et al., 1981) 62. TPU_62 LONGITRIOL 52941422 (Chen, Yan, Gao, Cao, & Huang, 2014) 63. TPU_63 CHALCONE 637760 (Chang et al., 1997) 64. TPU_64 ELLIPTONE 160477 (Sharma et al., 2013) 65. TPU_65 3-HYDROXY-4-METHOXY-8,9-METHYLENEDIOXYPTEROCARPAN N/A (Wiart, 2017) 66. TPU_66 DESMOXYPHYLLIN B N/A (Touqeer, Saeed, & Ajaib, 2013) 67. TPU_67 DEHYROISODERRICIN N/A (Bhatnagar & Kapoor, 2000) 68. TPU_68 CYSTEIN 3036261 (Mohanraj et al., 2018) 69. TPU_69 PHYTOSTEROLS 12303662 (Mohanraj et al., 2018) 70. TPU_70 1-TRIACONTANOL 68972 (Mohanraj et al., 2018) 71. TPU_71 BETA-METHOXYCHALCONE 12634404 (Mohanraj et al., 2018) 72. TPU_72 BETA -HYDROXYCHALONE 6101979 (Mohanraj et al., 2018) 73. TPU_73 KANJONE 12305449 (Mohanraj et al., 2018) 74. TPU_74 VLLOSOL 5490819 (Mohanraj et al., 2018) 75. TPU_75 VILLINOL 14427377 (Mohanraj et al., 2018) 76. TPU_76 VILLOSIN 16733738 (Mohanraj et al., 2018) 3.2 Clustering and chemical distribution of phytochemicals of T. purpurea
The PCs are found to be dispersed among 32 chemical classes, out of which the classes of 8prenylated flavones and pterocarpans are shared by the maximum number of PCs (Figure 2A ). PCs confirmed the rule. The screened PCs at this level were considered as drug-like phytochemicals (DPCs) and were considered for the further network pharmacological analysis.
The ADMET values of 30 DPCs, refereed as DPCs (as mentioned in Section 2.2) are presented in the form of the box and whisker plot ( Figure 2B ). The list of 30 DPCs and their ADMET values can be checked in the Supplementary Table- 1.
Phytochemical-drugs similarity network (PC-DR network)
In order to select active compounds in the T. purpurea plant based on the PCs similarity with approved drugs of DrugBank, Tanimoto coefficients were calculated. The similarity between molecules is represented in the form of a network, where an edge is drawn between a PC and a drug only if the similarity between them was more than 40% (i.e. TC ≥ 0.4). For that purpose, PCs earlier passing the drug-likeliness criterion (i.e. 30 DPCs) were considered at this step. Out -5) . Detailed examination of the similarity network helped us to identify that the TPU_04 shares a similarity with 30 out of 75 drugs in the PC-DR network. Also, the maximum similarity of 0.6 exists between DB00553 and TPU_26. TPU_04; Rotenone, classified as moderately hazardous class II pesticide by the WHO is known for its broad-spectrum insecticidal and herbicidal properties (Organization, 2010) . This naturally occurring compound has gained massive attention from the scientific community as an investigational drug towards cancer treatment due to its mitochondrial dysfunction ability (Heinz et al., 2017) . TPU_26 (Fraxinol) which shows similarity with an approved drug methoxsalen has been suggested as an uvioresistent agent for its application in UV cosmetics when considered in its glucoside form (CN104367486A, 2015) . This shows that the plant T. purpurea is a significant source for providing active compounds that could be of considerable importance in future drugdesign approaches.
Phytochemical-protein target (PC-PT) network
To Figure 4(B) ). When analyzed for another important network centrality measure known as betweenness centrality ( ), TPU_04 returned the maximum value of 0.503 as compared to other DPCs. The high value signifies the importance of TPU_04 as a communicating agent in the overall network, highlighting its global information spreading capacity (Girvan & Newman, 2002) . other DPCs it possess the highest regulatory potential by targeting 68 PCOS proteins. C: High-confidence interaction (HCI) network; High confidence interactions among the DPCs and PCOS proteins were derived from DPC-PP network and a sub-network is constructed that is referred as HCI network. The HCI interaction were chosen on the basis of the interactions predicted by at-least two of the three protein-target prediction algorithms used in this study.
Other DPCs for which the value is high and therefore demand attention for detailed investigations are TPU_63, TPU_07 and TPU_57 with value 0.176, 0.096 and 0.093, respectively. When checked in the PC-DR network, to examine their existing similarity with DrugBank drugs, all of these DPCs (TPU_04, TPU_63, TPU_07 and TPU_57) were successfully mapped. This further strengthens the lead like (drug-like) properties of these DPCs for their future implication in the disease management.
High-confidence interaction pairs (HCI pairs) defined as pairs predicted by at-least two of the three considered protein-target prediction algorithms were also checked for their presence in the network. This is essential to identify high confidence regulatory DPCs so that they can be put forward for their detailed interaction studies with their respective protein targets and other invitro studies. In the DPC-PP network, 17 HCI pairs corresponding to the interactions of 8DPCs
with 12 PCOS proteins are identified and highlighted in the network (Figure 4 (C);
Supplementary Table-7) . It is interesting to note that among the above mentioned 4 DPCs highlighted at the level of betweenness centrality evaluation, 3 (TPU_04, TPU_57 and TPU_07) are constituent of the HCI pairs, also. We believe that these DPCs could be the key regulators of the PCOS proteins for which detailed investigation could be followed up to screen novel regulatory DPCs for PCOS.
Phytochemical, protein targets and biological pathways network (PC-PT-BP)
Drugs shown to target multiple proteins have the ability to regulate more than one diseaseassociated pathway. Thus, to explore the multi-pathway regulating effects of the T. purpurea, all the protein targets of PCs were mapped to the KEGG database. The information of the identified pathways was incorporated into the PC-PT network data to construct a tripartite network of PC-PT-BP consisting of 624 nodes (76 phytochemicals, 542 protein targets, 6 pathways) and 2,759 edges ( Figure 5A ). 270 unique human pathways, distributed among 6 categories i.e. metabolism, genetic information processing, cellular processes, organismal systems and human diseases, were shown to be regulated by the PCs of T. purpurea. The detailed mapping of all the PTs into different human pathways is given in Supplementary Table-8 Figure 5C ). Majority of the protein targets were associated with cell and cellular process, followed by organelle association and metabolic processes. The GO enrichment analysis revealed that T. purpurea possesses the ability to control the diverse functions of a human cell through their protein targets.
To spot the pathways targeted by PCOS proteins, a network specific to PCOS proteins and their regulatory human pathways referred to as PCOS PT-BP network was derived and analyzed for the enrichment analysis ( Figure 5D ). It was interesting to note that the highly enriched pathways in the network ( Figure 5D ) corresponds to the metabolic pathway (hsa01100), cancer-associated pathway (hsa05200) and PI3-Akt signaling (hsa04151) owing to 61, 57 and 40 PCOS proteins, respectively. The role of metabolic pathway and cancer-associated pathways in PCOS is well studied as the prevalence of metabolic syndrome accounts for 37.5% (Mandrelle et al., 2012) while the development of endometrial cancer is 2.7 fold in women with PCOS (Dumesic & Lobo, 2013) .
Although the association of PI3-Akt signaling in PCOS is well-studied from past several years, the effectiveness of traditional medicinal plants and plant-based formulations for their PI3K-AKT targeting capacity is still unexplored. Towards the exploration of beneficial effects of T.
purpurea in PCOS through PI3k-AKT signaling pathway, the protein targets of the plant (PTs of DPCs) were mapped to this pathway. As seen in the Supplementary Figure 1 , it was observed that the proteins got mapped at 20 locations in this pathway, which suggests that the phytochemicals of this plant may exert substantial control over the pathway.
Disease-association network construction and analysis
To infer about the regulatory effects of the T. purpurea against various human diseases, the protein targets of its constituent phytochemicals were searched for their disease association. Out of 542 PTs of 76 PCs, 446 PTs were found to be associated with at least one disease. It was interesting to note that the PTs of T. purpurea were involved in 2,918 different diseases, broadly classified into 25 categories, based on MeSH disease class (Supplementary Figure 2) . The highest numbers of protein targets were shown to be associated with Neoplasm and Nervous system diseases with 281 and 236 proteins, respectively. The anti-cancer properties of this plant on MCF-7 cell lines have demonstrated its efficacy in cancer management (Gulecha & Sivakuma, 2011) . The high association of the P01375 (TNF; Tumor Necrosis Factor) with 343 diseases reflect the relative importance of this protein as a potential target. Compared to normal patients, the high concentration of TNF-α has been linked to observed androgen access and insulin resistance in PCOS patients (Gao, Gu, & Yin, 2016) . When checked for the regulatory DPCs against P01375, the association of the proteins with TPU_04 (Rotenone) came into light.
Since we are also interested in exploring the effectiveness of T. purpurea against the PCOS comorbid diseases, proteins constituting the PCOS-pool alongwith the derived disease associations were used to develop a PP-DA (PCOS-protein-Disease-association) network ( Figure 6 ). As seen in PP-DA network having network size of 2,664 nodes (261 PCOS proteins and 2,403 disease classes) and 9,343 edges, schizophrenia (a mental disorder, C0036341) is found to share the maximum number of PCOS-proteins i.e. 343. Although the direct association of this disease with PCOS is less explored, a large number of studies have related PCOS with various mental as well as psychiatric disorders (Blay, Aguiar, & Passos, 2016; Hung et al., 2014) . While the PCOS genes are associated with 2,403 diseases, high degree of interconnections apart from the schizophrenia were found with C0006142 (breast cancer), C0376358 (prostate cancer), C0033578 (prostate cancer) and C3714756 (Intellectual disability/ mental retardation) via 69, 63, 63 and 56 PCOS proteins, respectively. Detailed mapping of the PCOS proteins into various disease classes is given in the Supplementary Table 9 .
Our specific investigations in the form of two case studies are detailed in the following subsections.
Case study-I: Investigation of regulatory DPCs effective against PCOS comorbidities.
Literature data suggests that the association of PCOS with neurological disorders, especially; bipolar disorder (BPD), depression and anxiety are of high confidence. Earlier reported studies provided the evidence that the risk of depression among the women affecting with PCOS is linked to insulin resistance, where an elevated level of insulin has been observed in the patients when assessed by HOMA-IR (Homeostasis Model Assessment of Insulin Resistance) (Greenwood, Pasch, Shinkai, Cedars, & Huddleston, 2015) . Also, a cross-sectional based observation study shows that the severity of symptoms associated with anxiety is much more prevalent in PCOS patients, compared to depression (Deeks, Gibson-Helm, & Teede, 2010) .
Comorbid association between PCOS and psychiatric disorders like BPD (Bipolar disorders) has
been observed at both pharmacotherapy dependent (especially valproate treatment) (McIntyre, Mancini, McCann, Srinivasan, & Kennedy, 2003) and valproate independent PCOS-BPD association studies (Klipstein & Goldberg, 2006) . To screen potential multi-targeting and synergistic regulators from the T. purpurea against the protein targets of these diseases, the following approach was adopted.
Firstly, high confidence disease associations of protein targets were screened from DisGeNET using the threshold score of > 0.05. Gene-disease association (GDA) score (S) by DisGeNET ranges in between 0-1, in which both data-mining and literature-based associations are being taken into consideration while calculating the score. As described by DisGeNET, the score (S) is given by; Using this criterion, 579, 235 and 740 proteins were selected corresponding to BPD, anxiety and depression, respectively. Using a similar strategy, 223 proteins specific to PCOS were chosen for further analysis. The proteins were mapped into the PC-PT network to identify their potential regulators from the drug-like phytochemical pool of T. purpurea. Upon mapping, 30 DPCs were found to interact with 83 proteins associated with the above discussed four classes of diseases using 214 compound-protein pairs ( Figure 7A) . The multi-disease associations of a protein were observed at this point, where multiple proteins overlap between the 4 classes of diseases discussed here as shown in Figure 7B .
The proteins specific to each disease class as well as those overlapping are given in ( Supplementary Table 10 ). For the identification of DPCs that may act on multiple scales, the protein targets of DPCs were mapped in the PP-DA network and proteins with the multi-disease association, considering the above 3 comorbid diseases were taken for further analysis. In this manner, 7 classes of proteins comprising 10 proteins were obtained and the number of proteins belonging to each class is given in Table 2 . The selected 10 proteins were mapped to PC-PT network to identify their regulatory DPCs. The 10 proteins were found to interact with 12 DPCs via 30 interactions. The network was analyzed in detail to identify multi-targeting and synergistic regulators. The investigations led to the screening of 8 DPCs against 6 protein targets ( Figure 7C) . Each interaction of the network is subjected to molecular docking analysis to identify their potential binding energy values (Table   3 ). Table 3 , it was observed that the maximum binding energy value of -10.1 kcal/mol exists between P11511 and TPU_22. The DPC TPU_22 is also capable of regulating the P03372 with a good binding energy value of -7.9 Kcal/mol. The protein P03372 (Estrogen receptor;
As seen in
ESR1gene) is known to be associated with above discussed 3 diseases i.e. PCOS, BPD and depression.
Previous studies have correlated the role of ESR1 gene in PCOS via estrogen metabolism (Jiao et al., 2018) . Depression-like behavior in postpartum rats was shown to be associated with estrogen-mediated metabolism (Furuta et al., 2013) . While in BPD subjects, ESR1 is shown to be associated with behavioral traits (Pinsonneault et al., 2017) . This suggests that the role of TPU_22 is highly noteworthy in dealing with the co-morbidities associated with PCOS. When checked in the phytochemical-drugs similarity network (PC-DR), the compound shows its similarity with 12 drugs, which further strengthens the drug-like potential of this phytochemical.
Along with TPU_22, TPU_51 and TPU_57, TPU_07, TPU_66 on the ESR1 proteins show the binding energies in the range of -7.9 Kcal/mol to -9.0 Kcal/mol. We propose these compounds for future in-vitro as well as in-vitro studies to decipher the synergistic actions of these molecules to get detailed insights about their mechanism of action to further strengthen the anti-PCOS effects of the T. purpurea. Also, the multi-targeting potential of TPU_07 is worthy of attention, where the compound can regulate 5 proteins of the above considered 10 proteins.
When checked in detail for the molecular interactions of TPU_04 with its interacting proteins, the phytochemical shows good binding energy value of -8.6 and -8.0 with P03372 and P11511, respectively. As already discussed about the association of P03372 with PCOS, BPD and depression, the protein could be considered as a potential target of TPU_07. Interaction analysis of the docked complex of TPU_07 with P03372 shows that the phytochemical holds the ability to form hydrogen bond with the protein at arginine (Arg 394), glycine (Gly 521) and histidine (His 524) residues. As seen in Figure 7D , the protein-ligand complex is also stabilized by the hydrophobic interactions governed by 12 residues of the protein. When checked for the molecular interactions of TPU_07 with P11511, the formation of strong H-bond governed by arginine (Arg115) and serine (Ser314) residues further strengthens the molecular interaction between the protein-ligand complex, leading to a stable interaction pair with P11511. Binding energy of the protein (P11511) shows that the protein possesses the ability to interact with TPU_07 with 8.0 kcal/mol of energy. The protein (P11511; aromatase enzyme) is associated with PCOS and depression (as seen in Table- for their lowered side effects compared to the well-known oral OIA, clomiphene citrate (Misso et al., 2012) . This suggests that TPU_07 could be of promising role as a potential aromatase inhibitor and the investigation require experimental support from in-vitro and in-vivo inhibition studies.
In the similar manner, the network can also be checked for DPCs that may work in synergism to regulate a protein of interest. The involvement of the protein targets of T. purpurea in diverse class of diseases shows that the plant possesses the ability to work on multiple scales, highlighting the ethnopharmacological importance of the plant.
Case study II: Construction of PCOS specific PPI network (PCOS-PIN) and examining its modules regulated by T. purpurea
To ascertain the comprehensive interactions of PCOS genes on the entire human system, a PPI network specific to PCOS proteins was constructed and analyzed in detail. The construction of PCOS-PIN follows the development of a high-confidence human-PPI from STRING database with the confidence score of ≥ 0.9. A total of 7,972 PCOS proteins were searched in the human-PPI, resulting in the mapping of 4,456 proteins. The 4,456 proteins were having the tendency to interact with each other using 35,197 interactions, the network corresponding to these interactions constitute PCOS-PIN ( Figure 8A , Supplementary Table 11 ). The network analysis of the PCOS-PIN shows that node-degree distribution follows a power-law distribution with = 3014.9 .
( Figure 8B ). Since proteins tend to work together in a group, therefore the obtained network was subjected for the cluster (module) analysis to identify potential clusters and their associated proteins using the MCODE algorithm (Bader & Hogue, 2003) . Module analysis of the network shows that PCOS-PIN is regulated by multiple modules, where proteins associated with each module or cluster work in a coordinated manner to provide structural and functional integrity to the PIN. Top 10 modules with dense connections were taken for the subsequent analysis and were subjected for GO-based annotation using DAVID (Dennis et al., 2003) . This is essential to identify the functional role of the clusters in the human system in relation to PCOS. This also aids towards understanding the complex inter-relationship between the genes associated with a particular cluster and their functional relevance in the pathogenesis of PCOS.
Functional association of the clusters shows that proteins of the PCOS-PIN network are involved in the regulation of various cellular events, the majority being associated with signaling events of the cell or signal transduction pathways i.e. module-2, 3, 5, 6 and 7. As given in Supplementary   Table- 12, it can also be observed that PCOS proteins also exert their effects on regulating apoptotic process via module-8. Altered expression of genes associated with apoptotic process has been observed in the endometrium of the women suffering from PCOS, a study from China reports that the level of bax-gene is significantly higher in PCOS compared to normal levels (Maliqueo et al., 2003; Wu et al., 2017) . The participation of the PCOS protein in the regulation of other cellular events like rRNA processing, mitochondrial electron transport, response to DNA damage and transcription regulation could be linked to the proteins of module 1, 4, 9 and 10, respectively.
As the case-study aims towards examining the module regulatory potential of the phytochemicals of T. purpurea, the proteins associated with a protein-target list of 30 DPCs (i.e. 278 proteins)
were searched for their participation in the modules. Mapping of 278 proteins onto the considered 10 highly clustered modules could help us to identify the high regulatory role of the DPCs towards module-3 and module-6 as these modules are rich in protein associated with the protein-target list of DPCs. Majority of the proteins of module-3 are associated with "steroid hormone-mediated signaling pathway" where irregular steroid hormones level (Doi, Al-Zaid, Towers, Scott, & Al-Shoumer, 2005) , altered steroid metabolism (Oróstica et al., 2016) and over expression of steroid receptors (Maliqueo et al., 2003) have been observed in the cases of PCOS.
Proteins of module-6 show their participation in the "signal transduction" event. The role of association of various signaling events like PI3k-Akt (Li et al., 2017; Makker, Goel, Das, & Agarwal, 2012) , cAMP, WNT, LH and androgen signaling (Dumesic & Richards, 2013) with the pathogenesis of PCOS are well known.
For the detailed investigation about the information of DPCs of T. purpurea towards regulating module-3 and module-6, the proteins of both the modules were back mapped in PC-PT network and a sub-network corresponding to module proteins and their regulatory DPCs were constructed. As seen in Figure 8C , a total of 18 DPCs have the ability to regulate both the modules, where 10 DPCs can target the proteins of module-3 and 12 DPCs can target module-6.
The role of 4 DPCs (TPU_57, TPU_51, TPU_07 and TPU_04) in regulation of both the modules is also highlighted in this figure, where these 4 DPCs possess the tendency to directly target 7 and 8 proteins (shown in red outlined circles in Figure 8C ) of module-3 and module-6, respectively. Among the 4 DPCs, the phytochemicals corresponding to TPU_04, TPU_07 and TPU_57 should be given special attention, because in addition to their multi-module regulatory effect, the phytochemicals possess high betweenness centrality values in the PC-PT network. The structural similarity of these phytochemicals with the existing drugs of DrugBank, as seen in PC-DR network further supports the need for their detailed investigation towards the design of therapeutically active compounds against PCOS.
In a similar manner, other modules can be studied and checked for the DPCs for their multimodule participation.
Summary:
Polycystic ovarian syndrome (PCOS) comprises a spectrum of reproductive and nonreproductive complications with a high rate of prevalence amongst the women of reproductive age. Being the major cause of infertility, this syndrome has always gathered the attention of protein targets is also examined and presented using pathway mapping studies. The PI3k-Akt pathway acts as a major source of the signaling events towards extracellular response where activation of the same can be correlated with endometrial cancer observed in case of PCOS.
Investigation of regulatory DPCs effective to deal the major comorbidities associated with PCOS i.e. anxiety, depression and BPD (bipolar disorders) is also highlighted in this work and is discussed as a special case study. 8 potential regulators of T. purpurea against 6 PCOS proteins associated with its comorbid diseases were also identified in this work and studied for their docking and interaction analysis. The phytochemicals showing good binding affinity towards their protein targets were also evaluated for their similarity against currently available approved drugs present in DrugBank. TPU_22, TPU_51, TPU_57, TPU_07 and TPU_66 are the compounds being reported in this study to have substantial therapeutic relevance against the PCOS and its associated comorbidities. Augmenting the results obtained in this study with in-vivo and in-vitro will be of substantial help towards understanding the detailed mechanism of PCOS pathogenesis and design of future PCOS targeting drugs, effective to manage womenhealth. We believe that network-pharmacology based computational framework developed in this study will be a guiding source towards strengthening the anti-PCOS effect of T. purpurea and will also act as a platform in providing a modern scientific outlook to the traditional knowledge of Ayurveda and other traditional medicinal systems.
